Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma

Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jongmoo, Park, Jae Won, Kang, Min Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yeungnam University College of Medicine 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6784649/
https://www.ncbi.nlm.nih.gov/pubmed/31620633
http://dx.doi.org/10.12701/yujm.2019.00269
Descripción
Sumario:Stereotactic body radiotherapy (SBRT) is an advanced form of radiotherapy (RT) with a growing interest on its application in the treatment of hepatocellular carcinoma (HCC). It can deliver ablative radiation doses to tumors in a few fractions without excessive doses to normal tissues, with the help of advanced modern RT and imaging technologies. Currently, SBRT is recommended as an alternative to curative treatments, such as surgery and radiofrequency ablation. This review discusses the current status of SBRT to aid in the decision making on how it is incorporated into the HCC management.

Ejemplares similares